Involvement of transient receptor potential vanilloid 1 receptors in protease-activated receptor-2-induced joint inflammation and nociception

European Journal of Pain

Volumn 14, Issue 4, 2010, Pages 351-358

  Helyes, Zs ^a   Sandor K ^a   Borbély, É ^a   Tekus V ^a   Pinter E ^a   Elekes, K ^a   Toth D M ^a   Szolcsanyi J ^a   McDougall, J J ^b  

^a UNIVERSITY OF PÉCS   (Hungary)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Allodynia; Arthritis; Capsaicin sensitive sensory nerves; Inflammatory cytokines; Mechanical hyperalgesia

Indexed keywords

4 CHLORO N (3 METHOXYPHENYL)CINNAMAMIDE; INTERLEUKIN 1BETA; LEUCYLARGINYLGLYCYLISOLEUCYLLEUCYLSERINAMIDE; PEPTIDE; PROTEINASE ACTIVATED RECEPTOR 2; SERYLLEUCYLISOLEUCYLGLYCYLARGINYLLEUCINAMIDE; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRALGIA; ARTHRITIS; ARTICLE; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; EDEMA; GENE DELETION; HINDLIMB; HYPERALGESIA; INJECTION; JOINT SWELLING; KNEE; KNOCKOUT MOUSE; MALE; MOUSE; NOCICEPTION; NONHUMAN; PAIN; PRIORITY JOURNAL; RAT; SPECIES; TOUCH; WEIGHT; WEIGHT BEARING;

ANILIDES; ANIMALS; ARTHRITIS; BODY WEIGHT; CINNAMATES; CYTOKINES; ENZYME ACTIVATION; FOOT; HINDLIMB; HYPERALGESIA; INJECTIONS, INTRA-ARTICULAR; MALE; MECHANORECEPTORS; MICE; MICE, INBRED C57BL; OLIGOPEPTIDES; PAIN; PAIN MEASUREMENT; PAIN THRESHOLD; RATS; RATS, WISTAR; RECEPTOR, PAR-2; TRPV CATION CHANNELS;

EID: 77950299777     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2009.07.005     Document Type: Article

References (62)

1. Amadesi S., Nie J., Vergnolle N., Cottrell G.S., Grady E.F., Trevisani M., et al. Protease-activated receptor 2 sensitizes the capsaicin receptor transient receptor potential vanilloid receptor 1 to induce hyperalgesia. J Neurosci 24 (2004) 4300-4312
2. Amadesi S., Cottrell G.S., Divino L., Chapman K., Grady E.F., Bautista F., et al. Protease-activated receptor 2 sensitizes TRPV1 by protein kinase Cε- and A-dependent mechanisms in rats and mice. J Physiol 575 (2006) 555-571
3. Boileau C., Amiable N., Martel-Pelletier J., Fahmi H., Duval N., and Pelletier J.-P. Activation of protease-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and pro-inflammatory pathways capable of inducing cartilage degeneration: a basic science study. Arthritis Res Ther 9 (2007) R121-R130
4. Bölcskei K., Helyes Zs., Szabó A., Sándor K., Petho{combining double acute accent} G., Elekes K., et al. Investigation of the role of TRPV1 receptors in acute and chronic nociceptive processes using gene-deficient mice. Pain 117 (2005) 368-376
5. Busso N., Frasnelli M., Feifel R., Cenni B., Steinhoff M., Hamilton J., et al. Evaluation of protease-activated receptor 2 in murine models of arthritis. Arthritis Rheum 56 (2007) 101-107
6. Cenac N., and Vergnolle N. Proteases and protease-activated receptors (PARs): novel signals for pain. Curr Top Med Chem 5 (2005) 569-576
7. Cenac N., Coelho A.M., Nguyen C., Compton S., Andrade-Gordon P., McNaughton W.K., et al. Induction of intestinal inflammation in mouse by activation of protease-activated receptor-2. Am J Pathol 161 (2002) 1903-1915
8. Cenac N., Andrews C.N., Holzhausen M., Chapman K., Cottrell G., Andrade-Gordon P., et al. Role of protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 117 (2007) 636-647
9. Cocks T.M., Fong B., Chow J.M., Anderson G.P., Frauman A.G., Goldie R.G., et al. A protective role for protease-activated receptors in the airways. Nature 198 (1999) 156-160
10. Coelho A.-M., Ossovskaya V., and Bunnett N.W. Protease-activated receptor-2: physiological and pathophysiological roles. Curr Med Chem Cardiovasc Hematol Agents 1 (2003) 61-72
11. Costa R., Marotta D.M., Manjavachi M.N., Fernandes E.S., Lima-Garcia J.F., Paszcuk A.F., et al. Evidence for the role of neurogenic inflammation components in trypsin-elicited scratching behaviour in mice. Br J Pharmacol 154 (2008) 1094-1103
12. Cottrell G.S., Amadesi S., Schmidlin F., and Bunnett N.W. Protease-activated receptor 2: activation, signalling and function. Biochem Soc Trans 31 (2003) 1191-1197
13. Dai Y., Moriyama T., Higashi T., Togashi K., Kobayashi K., Yamanaka H., et al. Protease-activated receptor-2-mediated potentiation of transient receptor potential vanilloid subfamily 1 activity reveals a mechanism for protease-induced inflammatory pain. J Neurosci 24 (2004) 4293-4299
14. D'Andrea M.R., Derian C.K., Leturcq D., Baker S.M., Brunmark A., Ling P., et al. Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues. J Histochem Cytochem 46 (1998) 157-164
15. Ferrell W.R., Lockhart J.C., Kelso E.B., Dunning L., Plevin R., Meek S.E., et al. Essential role for protease-activated receptor-2 in arthritis. J Clin Invest 111 (2003) 35-41
16. Fiorucci S., and Distrutti E. Role of PAR2 in pain and inflammation. Trends Pharmacol Sci 23 (2002) 153-155
17. Grant A.D., Cottrell G.S., Amadesi S., Trevisani M., Nicoletti P., Mterazzi S., et al. Protease-activated receptor 2 sensitizes the transient receptor potential vanilloid 4 ion channel to cause mechanical hyperalgesia in mice. J Physiol 578 (2007) 715-733
18. Gu Q., and Lee L.-Y. Hypersensitivity of pulmonary chemosensitive neurons induced by activation of protease-activated receptor-2 in rats. J Physiol 574 (2006) 867-876
19. Helyes Zs., Pintér E., Németh J., and Szolcsányi J. Pharmacological targets for the inhibition of neurogenic inflammation. Curr Med Chem 2 (2003) 191-218
20. Helyes Zs., Szabó A., Németh J., Jakab B., Pintér E., Bánvölgyi A., et al. Anti-inflammatory and analgesic effect of somatostatin released from capsaicin-sensitive sensory nerve terminals in Freund's adjuvant-induced chronic arthritis model of the rat. Arthritis Rheum 50 (2004) 1677-1685
21. Helyes Zs., Pintér E., Németh J., Sándor K., Elekes K., Szabó A., et al. Effects of the somatostatin receptor subtype 4 selective agonist J-2156 on sensory neuropeptide release and inflammatory reactions in rodents. Br J Pharmacol 149 (2006) 405-415
22. Hollenberg M.D., and Compton S.J. International union of pharmacology. XXVIII: protease-activated receptors. Pharmacol Rev 54 (2002) 203-217
23. Holzer P. Peptidergic sensory neurons in the control of vascular functions: mechanisms and significance in the cutaneous and splanchnic vascular beds. Rev Physiol Biochem Pharmacol 121 (1992) 49-146
24. Hoogerwerf W.A., Zou L., Shenoy M., Sun D., Micci M.A., Lee-Hellmich H., et al. The protease-activated receptor 2 is involved in nociception. J Neurosci 21 (2001) 9036-9042
25. Jancsó-Gábor A., and Szolcsányi J. Action of rare earth metal complexes on neurogenic as well as on bradykinin-induced inflammation. J Pharm Pharmacol 22 (1970) 366-371
26. Kanke T., Takizawa T., Kabeya M., and Kawabata A. Physiology and pathology of protease-activated receptors (PARs): PAR-2 as a potential therapeutic target. J Pharmacol Sci 97 (2005) 38-42
27. Kawabata A., Kawao N., Kuroda R., Tanaka A., Itoh H., and Nishikawa H. Peripheral PAR-2 triggers thermal hyperalgesia and nociceptive responses in rats. NeuroReport 12 (2001) 715-719
28. Kawabata A., Kinoshita M., Kuroda R., and Kakehi K. Capsazepine partially inhibits neurally mediated gastric mucus secretion following activation of protease-activated receptor 2. Clin Exp Pharmacol Physiol 29 (2002) 360-361
29. Kawao N., Ikeda H., Kitano T., Kuroda R., Sekiguchi F., Kataoka K., et al. Modulation of capsaicin-evoked visceral pain and referred hyperalgesia by protease-activated receptors 1 and 2. J Pharmacol Sci 94 (2004) 277-285
30. Kelso E.B., Lockhart J.C., Hembrough T., Dunning L., Plevin R., Hollenberg M.D., et al. Therapeutic promise of proteinase-activated receptor-2 antagonism in joint inflammation. J Pharmacol Exp Ther 316 (2006) 1017-1024
31. Lindner J.R., Kahn M.L., Coughlin S.R., Sambrano G.R., Schauble E., Bernstein D., et al. Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J Immunol 165 (2000) 6504-6510
32. Macfarlane S.R., Seatter M.J., Kanke T., Hunter G.D., and Plevin R. Protease-activated receptors. Pharmacol Rev 53 (2001) 245-282
33. Maggi C.A. Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog Neurobiol 45 (1995) 1-98
34. McDougall J.J. Arthritis and pain: neurogenic origin of joint pain. Arthritis Res Ther 8 (2006) 220-229
35. McDougall J.J., Zhang C., Cellars L., Joubert E., Dixon C., and Vergnolle N. Triggering of protease-activated receptor 4 leads to joint pain and inflammation in mice. Arthritis Rheum 60 (2009) 728-737
36. McIntosh K.A., Plevin R., Ferrell W.R., and Lockhart J.C. The therapeutic potential of protease-activated receptors in arthritis. Curr Opin Pharmacol 7 (2007) 334-338
37. McLean P.G., Aston D., Sarkar D., and Ahluwalia A. Protease-activated receptor-2 activation causes EDHF-like coronary vasodilation: selective preservation in ischemia/reperfusion injury: involvement of lipoxygenase products, VR1 receptors, and C-fibers. Circ Res 90 (2002) 465-472
38. Molino M., Barnathan E.S., Numerof R., Clark J., Dreyer M., Cumashi A., et al. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 272 (1997) 4043-4049
39. Nakano S., Mishiro T., Takahara S., Yokoi H., Hamada D., Yukata K., et al. Distinct expression of mast cell tryptase and protease activated receptor-2 in synovia of rheumatoid arthritis and osteoarthritis. Clin Rheumatol 26 (2007) 1284-1292
40. Palmer H.S., Kelso E.B., Lockhart J.C., Sommerhoff C.P., Plevin R., Goh F.G., et al. Protease-activated receptor 2 mediates the proinflammatory effects of synovial mast cells. Arthritis Rheum 56 (2007) 3532-3540
41. Paszcuk A.F., Quintao N.L.M., Fernandes E.S., Juliano L., Chapman K., Andrade-Gordon P., et al. Mechanisms underlying the nociceptive and inflammatory responses induced by trypsin in the mouse paw. Eur J Pharmacol 581 (2008) 204-215
42. Russell FA., and McDougall JJ. Protease activated receptor (PAR) involvement in mediating arthritis pain and inflammation. Inflam Res 58 (2009) 119-126
43. Saifeddine M., al-Ani B., Cheng C.H., Wang L., and Hollenberg M.D. Rat protease-activated receptor-2 (PAR-2): cDNA sequence and activity of receptor-derived peptides in gastric and vascular tissue. Br J Pharmacol 118 (1996) 521-530
44. 4 receptor selective agonist J-2156 in acute and chronic pain models. Eur J Pharmacol 539 (2006) 71-75
45. Schmelz M., Zeck S., Raithel M., and Rukwied R. Mast cell tryptase in dermal neurogenic inflammation. Clin Exp Allergy 29 (1999) 695-702
46. Schmidlin F., Amadesi S., Dabbagh K., Lewis D.E., Knott P., Bunnett N.W., et al. Protease-activated receptor 2 mediates eosinophil infiltration and hyperreactivity in allergic inflammation of the airway. J Immunol 169 (2002) 5315-5321
47. Seeliger S., Derian C.K., Vergnolle N., Bunnett N.W., Nawroth R., Schmelz M., et al. Proinflammatory role of protease-activated receptor-2 in humans and mice during cutaneous inflammation in vivo. FASEB J 17 (2003) 1871-1885
48. Shimizu N., Nakahara T., Saito M., and Ishii K. Role of capsaicin-sensitive sensory nerves in protease-activated receptor-2-mediated contraction of rat urinary bladder. Eur J Pharmacol 569 (2007) 145-148
49. Steinhoff M., Corvera C.U., Thoma M.S., Kong W., McAlpine B.E., Caughey G.H., et al. Protease-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase. Exp Dermatol 8 (1999) 282-294
50. Steinhoff M., Vergnolle N., Young S.H., Tognetto M., Amadesi S., Ennes H.S., et al. Agonists of protease-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 6 (2000) 151-158
51. Su X., Camerer E., Hamilton J.R., Coughlin S.R., and Matthay M.A. Protease-activated receptor-2 activation induces acute lung inflammation by neuropeptide-dependent mechanisms. J Immunol 175 (2005) 2598-2605
52. Szabó A., Helyes Zs., Sándor K., Bite A., Pintér E., Németh J., et al. Role of TRPV1 receptors in adjuvant-induced chronic arthritis: in vivo study using gene-deficient mice. J Pharmacol Exp Ther 314 (2005) 111-119
53. Szolcsányi J. Antidromic vasodilatation and neurogenic inflammation. Agents Actions 23 (1988) 4-11
54. Szolcsányi J. Capsaicin-sensitive sensory nerve terminals with local and systemic efferent functions: facts and scopes of an unorthodox neuroregulatory mechanism. Prog Brain Res 113 (1996) 343-359
55. Szolcsányi J., Bölcskei K., Szabó A., Pintér E., Petho{combining double acute accent} G., Elekes K., et al. Analgesic effect of TT-232, a heptapeptide somatostatin analogue, in acute pain models of the rat and the mouse and in streptozotocin-induced diabetic hyperalgesia. Eur J Pharmacol 498 (2004) 103-109
56. Treede R.-D., and Magerl W. Multiple mechanisms of secondary hyperalgesia. Prog Brain Res 129 (2000) 331-341
57. Varga A., Németh J., Szabó A., McDougall J.J., Zhang C., Elekes K., et al. Effects of novel TRPV1 receptor antagonist SB266791 in vitro and in vivo in the rats. Neurosci Lett 385 (2005) 137-142
58. Vergnolle N. Protease-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo. J Immunol 163 (1999) 5064-5069
59. Vergnolle N. Protease-activated receptors and inflammatory hyperalgesia. Mem Inst Oswaldo Cruz 100 (2005) 173-176
60. Vergnolle N., McNaughton W.K., al-Ani B., Saifeddine M., Wallace J.L., and Hollenberg M.D. Protease-activated receptor 2 (PAR2)-activating peptides: identification of a receptor distinct from PAR2 that regulates intestinal transport. Proc Natl Acad Sci USA 95 (1998) 7766-7771
61. Vergnolle N., Bunnett N.W., Sharkey K.A., Brussee V., Compton S.J., Grady E.F., et al. Protease-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat Med 7 (2001) 821-826
62. Vergnolle N., Wallace J.L., Bunnett N.W., and Hollenberg M.D. Protease-activated receptors in inflammation, neuronal signalling and pain. Trends Pharmacol Sci 22 (2001) 146-152